Literature DB >> 21794395

[Relapsing polychondritis associated with a lymphoplasmocytic lymphoma and erythema nodosum].

Isabel Castrejón1, Mónica Ibáñez, Esther Vicente, Juan Luis Steegmann, Santos Castañeda.   

Abstract

Relapsing polychondritis is a disease of unknown etiology characterized by episodic inflammation of cartilaginous tissues. More rarely, it has been described as a paraneoplastic phenomenon mainly associated with myelodysplastic syndromes or other haematologic diseases. We present a case of relapsing polychondritis associated to low degree lymphoplasmocytic lymphoma whose picture was punctuated by cutaneous erythema nodosum and anterior uveitis. The clinical evolution was satisfactory with glucocorticoids and rituximab treatment.
Copyright © 2007 Elsevier España S.L Barcelona. Published by Elsevier Espana. All rights reserved.

Entities:  

Year:  2008        PMID: 21794395     DOI: 10.1016/S1699-258X(07)73598-2

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  3 in total

1.  Relapsing polychondritis in Singapore: a case series and review of literature.

Authors:  Tyng Yu Chuah; Nai Lee Lui
Journal:  Singapore Med J       Date:  2016-03-07       Impact factor: 1.858

2.  A rare case of splenic marginal zone B-cell lymphoma mimicking relapsing polychondritis of the ear.

Authors:  Gary J Huang; Bryan Mendes; Kianoush Sheykholeslami
Journal:  Case Rep Otolaryngol       Date:  2014-12-02

3.  Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome.

Authors:  Haruki Matsumoto; Yuya Fujita; Masahiko Fukatsu; Takayuki Ikezoe; Kohei Yokose; Tomoyuki Asano; Naomi Tsuchida; Ayaka Maeda; Shuhei Yoshida; Honami Hashimoto; Jumpei Temmoku; Naoki Matsuoka; Makiko Yashiro-Furuya; Shuzo Sato; Mai Murakami; Hidenori Sato; Chiharu Sakuma; Kazumasa Kawashima; Norshalena Shakespear; Yuri Uchiyama; Hiroshi Watanabe; Yohei Kirino; Naomichi Matsumoto; Kiyoshi Migita
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.